FLOT2: A Unique Transmembrane Protein with Potential as A Drug Target

Target Name: FLOT2

NCBI ID: G2319

FLOT2

FLOT2: A Unique Transmembrane Protein with Potential as A Drug Target

FLOT2 (FLOT2 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the family of transmembrane protein (TMP) that is characterized by the presence of a transmembrane region and a cytoplasmic tail.

FLOT2 is unique among its family members because of its unique structure and its ability to interact with various signaling molecules. Its transmembrane region consists of four尾-helices that are arranged in a specific arrangement, known as a parallel beta-sheet, which is unique among TMP. This arrangement allows FLOT2 to form a highly stable transmembrane domain that is involved in its signaling functions.

FLOT2 is involved in a variety of physiological processes in the body, including the regulation of ion and water transport, cell signaling, and inflammation. One of its most well-known functions is its role in the regulation of sodium and potassium channels, which are responsible for the flow of electrical signals in and out of cells.

FLOT2 is also involved in the regulation of the volume of water in cells, which is critical for maintaining the integrity of cell structure and function. This is important for a variety of physiological processes, including cell signaling and ion transport.

FLOT2 is also involved in the regulation of inflammation, which is a critical function for maintaining the immune system and promoting tissue repair. This is important for preventing the progression of diseases and for maintaining the health and function of tissues.

FLOT2 is a potential drug target because of its unique structure and its involvement in a variety of physiological processes. Its transmembrane domain and its ability to interact with various signaling molecules make it an attractive target for drug development.

Research has shown that FLOT2 is involved in a variety of signaling pathways, including the regulation of ion and water transport, cell signaling, and inflammation. This makes it an attractive target for drug development.

FLOT2 has also been shown to be involved in the regulation of the volume of water in cells, which is critical for maintaining the integrity of cell structure and function. This is important for a variety of physiological processes, including cell signaling and ion transport.

FLOT2 is also involved in the regulation of inflammation, which is a critical function for maintaining the immune system and promoting tissue repair. This is important for preventing the progression of diseases and for maintaining the health and function of tissues.

Despite its potential as a drug target, FLOT2 is not yet a well-studied protein. There is a need for further research to understand its functions and its potential as a drug target.

In conclusion, FLOT2 is a unique and highly stable transmembrane protein that is involved in a variety of physiological processes in the body. Its transmembrane domain and its ability to interact with various signaling molecules make it an attractive target for drug development. Further research is needed to understand its functions and its potential as a drug target.

Protein Name: Flotillin 2

Functions: May act as a scaffolding protein within caveolar membranes, functionally participating in formation of caveolae or caveolae-like vesicles. May be involved in epidermal cell adhesion and epidermal structure and function

The "FLOT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLOT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets